Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Telomerase-associated protein 1 (TEP1) is a mammalian protein homologous to the Tetrahymena p80 telomerase component and is associated with the telomerase ribonucleoprotein complex[1][5]. TEP1 interacts with the telomerase RNA component and telomerase reverse transcriptase (TERT), but genetic knockout studies in mice show that TEP1 is not essential for telomerase activity or telomere length maintenance in vivo[1]. Beyond its association with telomerase, TEP1 is a structural component of the cytoplasmic vault particle, a large ribonucleoprotein of yet unclear function linked to intracellular transport or signaling. TEP1 binds RNA in both complexes, suggesting a general role in ribonucleoprotein assembly or localization[1]. There are no well-established drugs targeting TEP1, nor is it considered a classical drug target, biomarker, or therapeutic safety concern at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomerase-associated protein 1 (TEP1).